Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)
Saudi Arabia
· Delayed Price · Currency is SAR 155.30
-0.70 (-0.45%)
Apr 29, 2026, 3:10 PM AST
TADAWUL:4015 Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Net Income | 463.8 | 356.52 | 292.4 | 171.31 | 170.7 | Upgrade
|
| Depreciation & Amortization | 43.45 | 36.88 | 26.15 | 24.37 | 24.08 | Upgrade
|
| Other Amortization | 0.64 | 0.54 | 0.48 | 0.36 | 0.27 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.03 | -0.02 | 1.26 | 1.22 | -0.09 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 0.06 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.1 | 4.52 | -0.04 | - | 2.08 | Upgrade
|
| Loss (Gain) on Equity Investments | -13.84 | -18.57 | -4.41 | 0.32 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 2.42 | 11.39 | 2.1 | 2.35 | 2.25 | Upgrade
|
| Other Operating Activities | 32.06 | 36.83 | 27.3 | 54.79 | 2.97 | Upgrade
|
| Change in Accounts Receivable | -145.56 | -123.81 | 18.03 | 12.19 | 46.74 | Upgrade
|
| Change in Inventory | 6.05 | -55.39 | -114.43 | -7.52 | -16.71 | Upgrade
|
| Change in Accounts Payable | 13.55 | 20.93 | 44.53 | -11.54 | -3.59 | Upgrade
|
| Change in Other Net Operating Assets | 3.6 | -6.57 | 2.55 | -18.53 | - | Upgrade
|
| Operating Cash Flow | 406.29 | 263.3 | 295.92 | 229.33 | 228.7 | Upgrade
|
| Operating Cash Flow Growth | 54.31% | -11.02% | 29.04% | 0.28% | -12.69% | Upgrade
|
| Capital Expenditures | -53.04 | -56.83 | -45.18 | -86.12 | -126.79 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | 0.34 | 0.05 | 0.15 | 0.14 | Upgrade
|
| Sale (Purchase) of Intangibles | -7.87 | -0.17 | -0.6 | -1.53 | -0.02 | Upgrade
|
| Investment in Securities | - | -5.6 | -31.72 | 33.02 | -19.08 | Upgrade
|
| Other Investing Activities | -7.89 | - | - | - | 2.48 | Upgrade
|
| Investing Cash Flow | -68.79 | -62.25 | -77.44 | -54.48 | -143.26 | Upgrade
|
| Long-Term Debt Repaid | -0.95 | -0.31 | -0.24 | -0.35 | -95.02 | Upgrade
|
| Net Debt Issued (Repaid) | -0.95 | -0.31 | -0.24 | -0.35 | -95.02 | Upgrade
|
| Common Dividends Paid | -242.2 | -217 | -70 | -148.78 | -113.33 | Upgrade
|
| Financing Cash Flow | -243.15 | -217.31 | -70.24 | -149.13 | -208.35 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1.57 | -6.34 | -5.14 | 2.83 | - | Upgrade
|
| Net Cash Flow | 95.92 | -22.6 | 143.09 | 28.55 | -122.92 | Upgrade
|
| Free Cash Flow | 353.25 | 206.47 | 250.74 | 143.2 | 101.9 | Upgrade
|
| Free Cash Flow Growth | 71.09% | -17.66% | 75.09% | 40.52% | -10.15% | Upgrade
|
| Free Cash Flow Margin | 23.54% | 15.66% | 22.78% | 15.62% | 13.85% | Upgrade
|
| Free Cash Flow Per Share | 5.05 | 2.95 | 3.58 | 2.05 | 10.19 | Upgrade
|
| Cash Interest Paid | 1 | 21.74 | 1.18 | 13.23 | - | Upgrade
|
| Levered Free Cash Flow | 183.34 | 95.31 | 155.39 | 84.13 | 50.95 | Upgrade
|
| Unlevered Free Cash Flow | 183.46 | 95.37 | 155.46 | 84.2 | 50.95 | Upgrade
|
| Change in Working Capital | -122.36 | -164.85 | -49.32 | -25.39 | 26.44 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.